Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-16-134927
Filing Date
2016-08-02
Accepted
2016-08-02 16:34:57
Documents
1
Period of Report
2016-07-29

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 6314
  Complete submission text file 0001209191-16-134927.txt   7743
Mailing Address 135 BEAVER ST WATHAM MA 02452
Business Address 135 BEAVER ST WATHAM MA 02452 1-781-398-0700
INTERLEUKIN GENETICS INC (Issuer) CIK: 0001037649 (see all company filings)

EIN.: 943123681 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2835 In Vitro & In Vivo Diagnostic Substances

Mailing Address 5425 WISCONSIN AVENUE, SUITE 800 CHEVY CHASE MD 20815
Business Address
Florence Anthony A. Jr. (Reporting) CIK: 0001559827 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-32715 | Film No.: 161800953